Browsing by Keyword : Epstein-Barr Virus Infections
Showing results 1 to 12 of 12
| Pub Year | | Title | AJOU Author(s) |
| 2018 | | Alterations in the Rho pathway contribute to Epstein-Barr virus-induced lymphomagenesis in immunosuppressed environments | 이다근 |
| 2017 | | Clinical usefulness of F-18 FDG PET in lymphoepithelioma-like gastric carcinoma | 안영실, 윤준기, 이기명, 이다근, 이수진, 이제희, 한상욱 |
| 2006 | | Epstein-Barr virus in CD30 anaplastic large cell lymphoma involving the skin and lymphomatoid papulosis in South Korea. | 김유찬 |
| 2018 | | Epstein-Barr virus positivity is associated with angiogenesis in, and poorer survival of, patients receiving standard treatment for classical Hodgkin's lymphoma | 고영화, 한재호 |
| 2015 | | Epstein-Barr virus-positive nodal T/NK-cell lymphoma: an analysis of 15 cases with distinct clinicopathological features. | 한재호 |
| 2016 | | Frequent EBV positivity in conventional adenocarcinomas occurring simultaneously with EBV-associated gastric cancers | 김영배, 이다근, 허훈 |
| 2019 | | Functional loss of ARID1A is tightly associated with high PD-L1 expression in gastric cancer | 김영배, 이다근 |
| 2011 | | Generalized granuloma annulare possibly associated with acute Epstein-Barr virus infection. | 김유찬, 박준은 |
| 2015 | | Hydroa vacciniforme-like lymphoma misdiagnosed as cutaneous lupus erythematosus. | 김유찬 |
| 2020 | | Hydroa vacciniforme-like lymphoproliferative disorder in Korea | 김유찬 |
| 2024 | | Open-Label, Multicenter, Randomized, Biomarker-Integrated Umbrella Trial for Second-Line Treatment of Advanced Gastric Cancer: K-Umbrella Gastric Cancer Study | 이현우 |
| 2024 | | Second-line chemoimmunotherapy with nivolumab and paclitaxel in immune-related biomarker-enriched advanced gastric cancer: a multicenter phase Ib/II study | 이현우 |
1
